SomnoMed Limited (ASX:SOM)
Australia · Delayed Price · Currency is AUD 0.3350
+0.0050 (1.52%)
Aug 28, 2026, 4:10 PM AEST
SomnoMed Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 114.53 | 111.49 | 91.65 | 83.62 | 72.58 | |
Revenue Growth | 2.73% | 21.65% | 9.61% | 15.20% | 15.75% |
Cost of Revenue | 44.51 | 44.76 | 36.52 | 31.69 | 28.3 |
Gross Profit | 70.02 | 66.73 | 55.13 | 51.92 | 44.28 |
Selling, General & Admin | 59.94 | 59.35 | 57.61 | 49.37 | 43.28 |
Operating Expenses | 69.04 | 67.04 | 63.46 | 55.53 | 48.41 |
Operating Income | 0.98 | -0.31 | -8.33 | -3.6 | -4.13 |
Interest Expense | -0.46 | -0.4 | -2.14 | -2.63 | -0.38 |
Interest & Investment Income | 0.09 | 0.02 | 0.03 | 0 | 0 |
Currency Exchange Gain (Loss) | -1.06 | -0.08 | 0.2 | -0.35 | 0.73 |
Other Non Operating Income (Expenses) | - | 0.01 | -1.03 | -0.46 | 0 |
EBT Excluding Unusual Items | -0.46 | -0.76 | -11.27 | -7.05 | -3.78 |
Other Unusual Items | - | - | - | - | 0.29 |
Pretax Income | -0.46 | -0.76 | -11.27 | -7.05 | -3.5 |
Income Tax Expense | 2.19 | 2.69 | 0.97 | 0.82 | 0.93 |
Earnings From Continuing Operations | -2.65 | -3.46 | -12.24 | -7.87 | -4.43 |
Earnings From Discontinued Operations | - | - | - | -0.13 | -0.01 |
Net Income to Company | -2.65 | -3.46 | -12.24 | -8 | -4.44 |
Net Income | -2.65 | -3.46 | -12.24 | -8 | -4.44 |
Net Income to Common | -2.65 | -3.46 | -12.24 | -8 | -4.44 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 217 | 212 | 121 | 79 | 79 |
Shares Outstanding (Diluted) | 217 | 212 | 121 | 79 | 79 |
Shares Change | 2.50% | 75.54% | 53.66% | 0.01% | 0.16% |
EPS (Basic) | -0.01 | -0.02 | -0.10 | -0.10 | -0.06 |
EPS (Diluted) | -0.01 | -0.02 | -0.10 | -0.10 | -0.06 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | 5.02 | 5.36 | -7.42 | -7.02 | 0.85 |
Free Cash Flow Per Share | 0.02 | 0.03 | -0.06 | -0.09 | 0.01 |
Gross Margin | 61.13% | 59.85% | 60.15% | 62.09% | 61.01% |
Operating Margin | 0.85% | -0.28% | -9.09% | -4.31% | -5.69% |
Profit Margin | -2.31% | -3.10% | -13.36% | -9.57% | -6.11% |
Free Cash Flow Margin | 4.38% | 4.81% | -8.10% | -8.39% | 1.17% |
EBITDA | 6.46 | 1.58 | -6.5 | -1.98 | -2.7 |
EBITDA Margin | 5.64% | 1.42% | -7.09% | -2.37% | -3.72% |
D&A For EBITDA | 5.49 | 1.89 | 1.83 | 1.62 | 1.43 |
EBIT | 0.98 | -0.31 | -8.33 | -3.6 | -4.13 |
EBIT Margin | 0.85% | -0.28% | -9.09% | -4.31% | -5.69% |